TP53 and cancer: Moreover, considering the importance of P53/MDM2 axis in cancer, it is remarkable, and possibly now rational, that FTLD-Tau mutations are linked to increased cancer incidence15, that hyperphosphorylated and insoluble Tau is detected in some cancers49, and that Tau expression correlates positively or negatively with survival in various cancers14.